Skip to main content

N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments.

Publication ,  Conference
Feng, Y; Zhou, Z; McDougald, D; Vaidyanathan, G; Zalutsky, M
Published in: JOURNAL OF NUCLEAR MEDICINE
2020

Duke Scholars

Published In

JOURNAL OF NUCLEAR MEDICINE

EISSN

1535-5667

ISSN

0161-5505

Publication Date

2020

Volume

61

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM

Published In

JOURNAL OF NUCLEAR MEDICINE

EISSN

1535-5667

ISSN

0161-5505

Publication Date

2020

Volume

61

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences